Abstract
Purpose
The aim of this study was to investigate the change of 3′-[18F]fluoro-3′-deoxy-l-thymidine (18FLT) uptake in normal bone marrow (BM) after inevitable radiation.
Procedures
Twenty-one non-small cell lung cancer patients who received carbon ion radiotherapy (CIRT) were studied with 18FLT-positron emission tomography/computed tomography (PET/CT) at pre- and post-CIRT. Radiation dose was calculated by radiation planning. Irradiated BM was divided into three groups (<10% of maximum dose, 10–30%, and >30%).
Results
18FLT uptake clearly decreased at >10% irradiated areas and mildly decreased at <10% areas. 18FLT uptake was lowest just after CIRT, somewhat increased at 3 months, and remained unchanged for more than 1 year. There was no significant difference between 10–30% and >30% areas.
Conclusion
18FLT revealed that BM function decreased by small dose such as <4.2–4.4 GyE/1 fraction of CIRT and is eradicated by >4.2–4.4 GyE/1 fraction.
Similar content being viewed by others
References
Shields AF, Grierson JR, Dohmen BM et al (1998) Imaging proliferation in vivo with [F-18] FLT and positron emission tomography. Nat Med 4:1334–1336
Salskov A, Tammisetti VS, Grierson J et al (2007) FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-deoxy-3′-[18F]fluorothymidine. Sem Nucl Med 37:429–439
Yamamoto Y, Nishiyama Y, Ishikawa S et al (2007) Correlation of (18)F-FLT and (18)F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:1610–1616
Saga T, Kawashima H, Araki N et al (2006) Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med 31:774–780
Buck AK, Bommer M, Sulgenbauer S et al (2006) Molecular imaging of proliferation in malignant lymphoma. Cancer Res 66:11055–11061
Kenny LM, Vigushin DM, Al-Nahhas A et al (2005) Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res 65:10104–10112
Francis DL, Visvikis D, Costa DC et al (2003) Potential impact of [18F]3-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging 30:988–994
van Westreenen HL, Cobben DC, Jager PL et al (2005) Comparison of 18FFLT PET and F-18 FDG PET in esophageal cancer. J Nucl Med 46:400–404
Cobben DC, van der Laan BF, Maas B et al (2004) F-18 FLT PET for visualization of laryngeal cancer: comparison with F-18 FDG PET. J Nucl Med 45:226–231
Hermann K, Ott K, Buck AK et al (2007) Imaging gastric cancer with PET and radiotracers F-18 FLT and F-18 FDG: a comparative analysis. J Nucl Med 48:1945–1950
Toyohara J, Waki A, Takamatsu S et al (2002) Basis of FLT as a cell proliferation marker comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. Nucl Med Biol 29:281–287
Agool A, Schot BW, Jager PL et al (2006) F-18 FLT PET in hemoatologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med 47:1592–1598
Miyamoto T, Yamamoto N, Nishimura H et al (2003) Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 66:127–140
Miyamoto T, Baba M, Sugane T et al (2007) Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2:916–926
Kanai T, Matsufuji N, Miyamoto T et al (2006) Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys 64:650–656
Martin SJ, Eisenbarth JA, Wagner-Utermann U et al (2002) A new precursor for the radiosynthesis of [18F]FLT. Nucl Med Biol 29:263–273
Nishimura H, Miyamoto T, Yamamoto N et al (2003) Radiographic pulmonary and pleural changes after carbon ion irradiation. Int J Radiat Oncol Biol Phys 55:861–866
Minohara S, Kanai T, Endo M et al (2000) Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 47:1097–1103
Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist, 6th edn, Chapter 8. Accute effects of total-body irradiation. Lippincott Williams & Wilkins, Philadelphia, pp 117–128
Higashi T, Fisher SJ, Brown RS et al (2000) Evaluation of early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med 41:2026–2035
Higashi K, Clavo AC, Wahl RL (1993) Does FDG uptake measure proliferative activity of human cancer cells? J Nucl Med 34:414–419
Everitt S, Hicks R, Ball D et al (2009) Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial F-18 FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 75:1098–1104
Menda Y, Ponto LB, Dornfeld KJ et al (2009) Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine (18F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy. J Nucl Med 50:1028–1035
Wieder HA, Geinitz H, Rosenberg R et al (2007) PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. Eur J Nucl Med Mol Imaging 34:878–883
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koizumi, M., Saga, T., Inubushi, M. et al. Uptake Decrease of Proliferative PET Tracer 18FLT in Bone Marrow after Carbon Ion Therapy in Lung Cancer. Mol Imaging Biol 13, 577–582 (2011). https://doi.org/10.1007/s11307-010-0363-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-010-0363-4